Filing Details
- Accession Number:
- 0001225208-15-022470
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-16 12:37:05
- Reporting Period:
- 2015-12-14
- Filing Date:
- 2015-12-16
- Accepted Time:
- 2015-12-16 12:37:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204663 | H John Weiland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | President And Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-14 | 33,569 | $97.69 | 112,978 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-14 | 5,242 | $183.34 | 107,736 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-14 | 5,904 | $184.56 | 101,832 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-12-14 | 8,606 | $185.09 | 93,226 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-14 | 19,721 | $184.12 | 73,505 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2015-12-14 | 33,569 | $0.00 | 33,569 | $97.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,190 | 2022-12-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,831 | Indirect | 401(k) Plan |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $182.74 to $183.73. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Shares withheld to pay taxes upon vesting of restricted stock units granted under the Company's 2003 Long Term Incentive Plan.
- Represents the weighted average sales price for price increments ranging from $184.74 to $185.54. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $183.74 to $184.72. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Includes 86.475 shares acquired under the Company's 401(k) Plan from February 7, 2015 to November 6, 2015.
- Options granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc.
- Of this option grant, 33,569 shares are currently exercisable and the remaning 11,190 options will vest on December 12, 2016.
Billionaire Hedge Funds
